Last Updated: November 9, 2026

Suppliers and packagers for QUELICIN PRESERVATIVE FREE

« Back to Dashboard


QUELICIN PRESERVATIVE FREE

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package Marketing Start
Hospira QUELICIN PRESERVATIVE FREE succinylcholine chloride INJECTABLE;INJECTION 008845 NDA Hospira, Inc. 0409-6629-02 25 VIAL, MULTI-DOSE in 1 TRAY (0409-6629-02) / 10 mL in 1 VIAL, MULTI-DOSE (0409-6629-12) 2005-04-30
>Applicant >Tradename >Generic Name >Dosage >NDA >NDA/ANDA >Supplier >Package Code >Package >Marketing Start

Quelicin Preservative-Free Suppliers and Distribution Channels

Last updated: August 1, 2026

Quelicin Preservative Free is a prescription injectable containing succinylcholine chloride, a depolarizing neuromuscular blocker used for rapid skeletal-muscle paralysis during anesthesia and emergency airway management. The branded product is supplied through Pfizer’s hospital pharmaceutical channel and major U.S. pharmaceutical wholesalers. [1][2]

Who supplies Quelicin Preservative Free?

The principal commercial suppliers and distribution channels are:

Supplier or channel Role Typical customer
Pfizer Hospital US Manufacturer and primary commercial source Hospitals, health systems, government accounts
McKesson Corporation Full-line pharmaceutical wholesaler Hospitals, surgery centers, pharmacies
Cardinal Health Full-line pharmaceutical wholesaler Hospitals and institutional buyers
Cencora, formerly AmerisourceBergen Full-line pharmaceutical wholesaler Health systems, group purchasing organizations
Morris & Dickson Pharmaceutical wholesaler Hospitals and regional health systems
Anda, Inc. Pharmaceutical distributor Institutional and pharmacy customers
Henry Schein Medical Medical and pharmaceutical distributor Ambulatory surgery centers and physician practices
Authorized hospital purchasing groups Contracting and procurement channel Integrated delivery networks and hospitals

Hospitals generally purchase Quelicin through a primary wholesaler rather than directly from a retail pharmacy. Direct Pfizer purchasing is typically reserved for institutional, government, or contracted accounts.

What is the NDC and package configuration for Quelicin?

Quelicin Preservative Free is marketed as succinylcholine chloride injection, USP. The commonly listed U.S. package configurations are:

Product Strength Package NDC
Quelicin 20 mg/mL 5 mL single-dose vial 0409-6629-05
Quelicin 20 mg/mL 10 mL multiple-dose vial 0409-6629-01

The 5 mL vial contains 100 mg of succinylcholine chloride. The 10 mL vial contains 200 mg. Product packaging and specific NDC availability can differ by wholesaler contract and purchasing account. [1][2]

Where can hospitals buy Quelicin Preservative Free?

Pfizer Hospital US

Pfizer is the branded manufacturer and the most direct source for institutional procurement. Hospitals can purchase through Pfizer’s hospital sales organization, contracted purchasing arrangements, or Pfizer-authorized wholesalers.

Pfizer’s hospital channel is relevant when:

  • A hospital requires branded Quelicin rather than a generic equivalent.
  • The account has a Pfizer purchasing agreement.
  • A wholesaler shows temporary backorder status.
  • The buyer needs manufacturer documentation, lot information, or product availability support.

McKesson

McKesson distributes injectable anesthetic and emergency medicines to hospitals, ambulatory surgery centers, and pharmacies. Buyers should search by both the product name and NDC because wholesaler catalogs may list Quelicin under succinylcholine chloride injection.

Cardinal Health

Cardinal Health supplies hospital pharmacies and health systems through institutional pharmaceutical distribution agreements. Account-specific eligibility, contract pricing, and inventory status determine whether Quelicin is available for purchase.

Cencora

Cencora distributes hospital pharmaceuticals and supports health-system procurement. Buyers may find the product under the generic description "succinylcholine chloride injection, USP" rather than the Quelicin brand name.

Morris & Dickson and Anda

These distributors can provide secondary or regional access for institutional purchasers. Availability depends on customer credentials, product allocation, and current wholesaler inventory.

Is Quelicin Preservative Free FDA approved?

Yes. Quelicin is an FDA-approved injectable formulation of succinylcholine chloride. The product labeling identifies it as a preservative-free injection. It is administered intravenously or intramuscularly by trained medical personnel for short-term neuromuscular blockade. [1]

The product is not an over-the-counter medicine. Commercial buyers must procure it through licensed pharmaceutical distribution channels, and healthcare facilities must maintain appropriate storage, handling, and controlled medication procedures.

What alternatives compete with Quelicin?

The principal alternatives are generic succinylcholine chloride injections and other branded or authorized institutional products containing the same active ingredient.

Product category Active ingredient Competitive position
Quelicin Succinylcholine chloride Branded Pfizer hospital product
Generic succinylcholine chloride injection Succinylcholine chloride Therapeutically equivalent or substitutable subject to formulary and procurement rules
Anectine or legacy branded products Succinylcholine chloride Historical or limited branded alternatives
Rocuronium injection Rocuronium bromide Nondepolarizing alternative for rapid-sequence intubation
Vecuronium injection Vecuronium bromide Nondepolarizing neuromuscular blocker with different onset and duration

Generic succinylcholine products may be listed by wholesalers without the Quelicin name. Procurement teams should compare the active ingredient, concentration, vial size, preservative status, route of administration, and FDA-approved labeling.

What should buyers verify before ordering?

Institutional purchasers should verify:

  1. The NDC and vial size.
  2. Whether the product is preservative-free.
  3. The concentration, typically 20 mg/mL.
  4. The supplier’s lot expiration date.
  5. Refrigerated or controlled-temperature shipping requirements.
  6. Whether the product is subject to allocation.
  7. The manufacturer or labeler identified on the invoice.
  8. The facility’s wholesaler contract and group purchasing organization terms.
  9. Whether the order is for Quelicin or a generic succinylcholine product.
  10. The supplier’s return and cold-chain policy.

Quelicin is a high-alert injectable medication. Purchasing departments should coordinate with pharmacy leadership and anesthesia services before substituting another succinylcholine presentation.

How does Quelicin compare with generic succinylcholine?

Quelicin and generic succinylcholine chloride injections contain the same active pharmaceutical ingredient. The commercial differences usually involve:

  • Labeler and manufacturer.
  • Package configuration.
  • Contract price.
  • Wholesaler availability.
  • Backorder exposure.
  • Packaging and vial design.
  • Institutional formulary status.
  • Manufacturer supply continuity.

A hospital may approve generic substitution through its formulary process, but automatic substitution is governed by facility policy, state law, and purchasing agreements. The generic product should be checked against the exact Quelicin specification, especially when a preservative-free presentation is required.

What is the supply-chain risk for Quelicin?

Supply risk is concentrated in injectable manufacturing, sterile filling capacity, raw-material availability, and hospital wholesaler allocation. Succinylcholine is an essential emergency and anesthesia medicine, so temporary disruptions can affect operating rooms, emergency departments, intensive-care units, and obstetric anesthesia services.

Hospitals commonly manage supply exposure by:

  • Maintaining more than one approved succinylcholine supplier.
  • Qualifying generic presentations in advance.
  • Tracking both branded and generic NDCs.
  • Monitoring FDA drug-shortage communications.
  • Maintaining an approved alternative such as rocuronium.
  • Reviewing vial-size substitution rules.
  • Coordinating pharmacy and anesthesia inventory forecasts.

Key Takeaways

  • Quelicin Preservative Free is a Pfizer-branded succinylcholine chloride injection.
  • The principal institutional supply route is Pfizer Hospital US and major wholesalers.
  • Major distribution channels include McKesson, Cardinal Health, Cencora, Morris & Dickson, Anda, and Henry Schein Medical.
  • Commonly listed presentations include 20 mg/mL in 5 mL and 10 mL vials.
  • The commonly listed NDCs are 0409-6629-05 and 0409-6629-01.
  • Generic succinylcholine chloride injections are the main direct purchasing alternatives.
  • Buyers should verify preservative status, NDC, vial size, cold-chain handling, and wholesaler allocation before ordering.

FAQs

Can retail pharmacies dispense Quelicin Preservative Free?

Retail pharmacies may be able to order it through pharmaceutical wholesalers, but Quelicin is primarily an institutional injectable product. Hospital pharmacies and ambulatory surgery centers are the usual purchasers.

Is Quelicin the same as succinylcholine?

Quelicin is a branded formulation of succinylcholine chloride injection. The active ingredient is succinylcholine chloride.

Does Quelicin require refrigeration?

Storage requirements should be confirmed against the current manufacturer labeling and shipment documentation. Institutional buyers should maintain the labeled temperature range throughout receipt and storage.

Can hospitals substitute generic succinylcholine for Quelicin?

Substitution depends on the hospital formulary, purchasing policy, state requirements, and the specific generic product’s formulation and package configuration.

Which distributor is usually the lowest-cost source for Quelicin?

The lowest net price depends on the hospital’s wholesaler contract, group purchasing organization, volume, manufacturer agreements, and current allocation status. List price alone does not determine the lowest acquisition cost.

References

  1. Pfizer Inc. (n.d.). Quelicin: Succinylcholine chloride injection, USP prescribing information. Pfizer labeling database.

  2. National Library of Medicine. (n.d.). DailyMed: Quelicin, succinylcholine chloride injection. U.S. National Library of Medicine.

  3. U.S. Food and Drug Administration. (n.d.). National Drug Code Directory. U.S. Department of Health and Human Services.

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.